Literature DB >> 18791840

Lymphocyte apoptosis, caspase activation and inflammatory response in septic shock.

G Delogu, G Famularo, G Tellan, M Marandola, A Antonucci, M Signore, S Marcellini, S Moretti.   

Abstract

BACKGROUND: We examined lymphocyte apoptosis, activity of caspases-1, -3, -8 and -9 and the relationship between those two events and inflammation response in septic shock.
MATERIALS AND METHODS: Blood samples were obtained within 24 h after diagnosis of septic shock from 16 patients to measure apoptosis, caspases-3, -8, -9 expression, changes in mitochondrial transmembrane potential and expression of Fas/FasL system of peripheral blood mononuclear cells (PBMCs). Moreover, serum levels of caspase-1 and blood concentrations of IL-6, IL-12, IL-15 and IL-18 were assessed.
RESULTS: PBMCs from patients with septic shock compared to control individuals exhibited a greatly increased frequency of apoptosis (39.10 +/- 7.33% vs 4.19 +/- 1.13%; p < 0.001), an over expression of caspases-3, -8, and -9 (p < 0.01, p < 0.05, p < 0.001 for caspases-3, -8 and -9, respectively) as well as of Fas/FasL system (p < 0.05) and significant changes in mitochondrial transmembrane potential. Blood levels of caspase-1 (101.5 +/- 18.2 pg/ml vs 9.09 +/- 2.7 pg/ml, p < 0.001) and of IL-6, IL-12, IL-15 and IL-18 were significantly higher in septic patients vs control (p < 0.0001, p < 0.05, p < 0.05 and p < 0.0001, respectively). Furthermore, a correlation linking IL-6 blood level with both the apoptotic rate (r(2) = 0.75; p = 0.001) and caspase-9 expression (r(2) = 0.92; p = 0.0001) of PBMCs was observed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18791840     DOI: 10.1007/s15010-008-7070-y

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  9 in total

1.  Prevention of lymphocyte apoptosis in septic mice with cancer increases mortality.

Authors:  Amy C Fox; Elise R Breed; Zhe Liang; Andrew T Clark; Brendan R Zee-Cheng; Katherine C Chang; Jessica A Dominguez; Enjae Jung; W Michael Dunne; Eileen M Burd; Alton B Farris; David C Linehan; Craig M Coopersmith
Journal:  J Immunol       Date:  2011-07-06       Impact factor: 5.422

2.  Cecal ligation and puncture-induced impairment of innate immune function does not occur in the absence of caspase-1.

Authors:  E D Murphey
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

Review 3.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

4.  Sustained high serum caspase-3 concentrations and mortality in septic patients.

Authors:  L Lorente; M M Martín; A Pérez-Cejas; A F González-Rivero; R O López; J Ferreres; J Solé-Violán; L Labarta; C Díaz; S Palmero; A Jiménez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-11-08       Impact factor: 3.267

5.  Serum caspase-9 levels are increased in patients with amyotrophic lateral sclerosis.

Authors:  Joanna Iłżecka
Journal:  Neurol Sci       Date:  2011-11-03       Impact factor: 3.307

6.  Leukocyte kinetics during the early stage acts as a prognostic marker in patients with septic shock in intensive care unit.

Authors:  Qing Li; Jianfeng Xie; Yingzi Huang; Songqiao Liu; Fengmei Guo; Ling Liu; Yi Yang
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.817

7.  Uncontrolled sepsis: a systematic review of translational immunology studies in intensive care medicine.

Authors:  David J Cain; Ana Gutierrez Del Arroyo; Gareth L Ackland
Journal:  Intensive Care Med Exp       Date:  2014-02-27

Review 8.  The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy.

Authors:  Hong-Yuan Lin
Journal:  Chin J Traumatol       Date:  2020-06-15

9.  Prognostic Significance of Preoperative Circulating Monocyte Count in Patients With Breast Cancer: Based on a Large Cohort Study.

Authors:  Jiahuai Wen; Feng Ye; Xiaojia Huang; Shuaijie Li; Lu Yang; Xiangsheng Xiao; Xiaoming Xie
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.